cultured for 3, 7, 14 and 21 days and several markers of osteogenesis were analysed. While the initial response of cells in 3-D seemed to exceed those cultured in 2-D, later markers showed that osteogenic differentiation of MSCs took longer in the 3-D environment. Significantly however, it was shown that complete scaffold mineralisation occurred by 21 days, demonstrating the potential of MSC-seeded collagen GAG scaffolds for bone tissue engineering.
The third paper by Fassina et al. looks at the effects of electromagnetic stimulation on human osteoblasts seeded onto porous polyurethane. In comparison with control conditions, electromagnetic stimulation caused higher cell proliferation, higher surface coating with decorin and type-I collagen, and increased calcium deposition demonstrating that the superficially modified biomaterial might be used in clinical applications as an osteoinductive implant for bone repair. This earned Lorenzo Fassina the ESEM prize for the best conference paper in the area of Cellular, Molecular and Tissue Engineering.
In the fourth paper, Pilliar et al. use a porous calcium polyphosphate (CPP) and chondrocytes in cell culture to develop a construct in which the pores anchor the cartilage. These biphasic constructs were implanted in sheep femoral condyle sites and left for short-term periods (3 to 4 months) or longer periods (9 months). Implant fixation within the condyle sites was achieved through bone ingrowth into the inferior CPP pores. The properties and characteristics of the in vitro-formed, short-and long-term implanted tissues were compared and the results indicated that such implants might be useful for repairing small subchondral defects.
Appropriately, the final paper in this Special Issue, by Dickson et al., reviews recent developments in the field of tissue engineering for orthopaedic applications. The authors note that medical implants which encourage natural tissue regeneration are more desirable than metallic implants, which may require a second procedure to remove them. Numerous polymeric materials, from natural and artificial sources, are under investigation as substitutes for skeletal tissue. For bone regeneration, cells (obtained mainly from bone marrow aspirate or as primary cell outgrowths from bone biopsies) can be combined with biodegradable polymeric materials and/or ceramics and absorbed growth factors so that osteoinduction is facilitated together with osteoconduction through the creation of bioactive rather than bioinert scaffold constructs. Relatively rapid biodegradation enables advantageous filling with natural tissue while loss of polymer strength before mass is disadvantageous. Innovative solutions are required to address this and other issues such as the biocompatibility of material surfaces and the use of appropriate scaffold topography and porosity to influence bone cell gene expression.
The challenge of tissue engineering is to mimic what happens in nature. To date, the highest rates of success have been achieved in the areas of skin and bladder regeneration where tissue-engineered material has been used successfully in the clinic. In orthopaedics, the greatest successes to date have been in the area of cartilage generation in vitro where some tissues have been implanted in patients. However, a fully functional, biocompatible, mechanically competent, vascularised tissue-engineered substitute for bone or cartilage remains to be developed. As more sophisticated biomaterials and bioreactors are developed, and as we learn more of the cell signalling mechanisms involved in tissue development, we will get closer to achieving these aims. Close collaboration between engineering and medicine will speed the process.
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